• 05 October 2015
    GSK and Pfizer complete transaction of meningitis assets, Mencevax and Nimenrix

    GlaxoSmithKline (GSK) and Pfizer have successfully completed the transfer of GSK’s meningitis vaccines Nimenrix® (Meningococcal serogroups A, C, W-135 and Y conjugate vaccine) and Mencevax® (Meningococcal serogroups A, C, W-135 and Y polysaccharide vaccine) which were acquired by Pfizer Ireland Pharmaceuticals (a subsidiary of Pfizer Inc), effective 1 October 2015.

    Read More
  • 14 September 2015
    Charity welcomes new vaccines but warns meningitis is still a threat

    International charity Meningitis Research Foundation is encouraging the public to take up new free meningitis vaccines for babies, teenagers and first time university students during Meningitis Awareness Week (14 -20 September).

    Read More
  • 13 September 2015
    CoMO Supports World Sepsis Day

    Today is World Sepsis Day, a day to raise awareness about the illness and to learn about what action must be taken to protect people all over the world. According to the Global Sepsis Alliance, globally, 20 to 30 million patients are estimated to be afflicted every year, with over 6 million cases of neonatal and early childhood sepsis and over 100,000 cases of maternal sepsis.

    Read More